High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality.
Philip J DevereauxAndre LamyMatthew T V ChanRené V AllardVladimir V LomivorotovGiovanni LandoniHong ZhengDomenico PaparellaMichael H McGillionEmilie P Belley-CôtéJoel L ParlowMalcolm J UnderwoodChew Yin WangNazari DvirnikMarat AbubakirovEvgeny FominskiyStephen ChoiStephen FremesFabrizio MonacoGerard UrrútiaMarialuz MaestreLudhmila A HajjarGraham S HillisNicholas L MillsVito MargariJoseph D MillsJ Stephen BillingEmily MethangkoolCarisi A PolanczykRoberto Sant'AnnaDmitry ShukevichDavid ConenPeter A KavsakMatthew J McQueenKatheryn BradyJessica SpenceYannick Le ManachRajibul MianShun Fu LeeShrikant I BangdiwalaSara HussainFlavia K BorgesShirley PettitJessica VincentGordon H GuyattSalim YusufJoseph S AlpertHarvey D WhiteRichard P Whitlocknull nullPublished in: The New England journal of medicine (2022)
The levels of high-sensitivity troponin I after cardiac surgery that were associated with an increased risk of death within 30 days were substantially higher than levels currently recommended to define clinically important periprocedural myocardial injury. (Funded by the Canadian Institutes of Health Research and others; VISION Cardiac Surgery ClinicalTrials.gov number, NCT01842568.).